FINWIRES · TerminalLIVE
FINWIRES

Guangdong Taienkang Pharmaceutical Directors Approve Capital Increase

By

Guangdong Taienkang Pharmaceutical (SHE:301263) directors approved the change in the company's registered capital and total share capital.

The registered capital rose to 510.6 million yuan from 425.5 million yuan, while the number of shares increased to 510.6 million from 425.5 million, according to a Thursday filing with the Shenzhen bourse.

Related Articles